Europe Single-use Medical Device Reprocessing Market Anticipated to Witness a CAGR of 6.1% by 2023 with Top Players: CENTURION MEDICAL PRODUCTS, HYGIA, JOHNSON & JOHNSON, MEDLINE INDUSTRIES, NESCIENTIFIC, RENU MEDICAL, STRYKER

The Europe single-use medical devices reprocessing market has been estimated to register a CAGR of 6.1% during the forecast period of 2018u20132023. Single-use device (SUD) reprocessing includes cleaning, disinfection, and sterilization. It helps hospitals to maintain patient care quality, while saving substantial amounts of money. With better regulatory policies in Germany, a higher quality of reprocessed devices is available in the market, which raises the market share during the forecast period compared to other countries in this region.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/17025
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Germany Expected to Dominate the Market
Germany is expected to dominate the market. The presence of well-established regulations and presence of major companies in SUDs such as Vanguard AG, which has several reprocessing sites in Europe, including several in Germany itself, help in the growth of this market in this country. The reprocessing helps in cost saving for items, such as the balloon catheters used in hospitals.

Major players-
CENTURION MEDICAL PRODUCTS, HYGIA, JOHNSON & JOHNSON, MEDLINE INDUSTRIES, INC., NESCIENTIFIC, INC., RENU MEDICAL, STRYKER, AND VANGUARD AG, amongst others.

Get Quality Discount @ https://marketprognosis.com/discount-request/17025
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Cost Savings through Reprocessing of Single-use Devices
The lowering of the overall cost of healthcare through the reprocessing of single-use devices is the primary factor driving this market. In Germany, the reprocessing has been regulated for over a decade with a large number of hospitals showing significant cost savings. It has been strictly subjected to monitoring and surveillance by public authorities and the European Union (EU)-accredited notified body. Similarly, in the United Kingdom, Medicines and Healthcare products Regulatory Agency (MHRA) legalized the use and manufacture of reprocessed single-use medical devices for use. In addition, it helps insurers and hospitals for better management and reduced healthcare costs with the improvement of the healthcare system.
Other major factors responsible are the rising significance of medical waste minimization and the positive effects on environment sustainability.

Preconceived Notion Regarding the Quality of Reprocessed Single-use Medical Devices
Despite the fact that the reprocessed SUDs are cost-saving including waste-reduction practice, still, there are several concerns being raised, which prevent many people to build trust on these devices. The patients and their families have often raised issues regarding patient safety, patient’s informed consent, manufacturing standards for both the original manufacturer and the reprocessing company including the potential ethical issues of “single-use” devices re-use. This preconceived notion directly impedes the growth of the market
Other factors impeding this market are the decreased manufacturer’s profit and regulatory scenario.

Browse Report @ https://marketprognosis.com/enquiry/17025
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.